mirtazapine has been researched along with Alloxan Diabetes in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahin, E | 2 |
| Bektur, E | 2 |
| Burukoglu Donmez, D | 1 |
| Baycu, C | 2 |
| Can, OD | 2 |
| Sahinturk, V | 1 |
| Ceyhan, E | 1 |
| Donmez, DB | 1 |
| Canbek, M | 1 |
2 other studies available for mirtazapine and Alloxan Diabetes
| Article | Year |
|---|---|
Mirtazapine suppresses sterile inflammation through NLRP3-inflammasome in diabetic rat kidney.
Topics: Animals; Apoptosis; Diabetes Mellitus, Experimental; Inflammasomes; Inflammation; Interleukin-1beta; | 2019 |
Beneficial effect of mirtazapine on diabetes-induced hyperalgesia: involvement of TRPV1 and ASIC1 channels in the spinal cord and dorsal root ganglion.
Topics: Acid Sensing Ion Channels; Animals; Capsaicin; Diabetes Mellitus, Experimental; Disease Models, Anim | 2019 |